Senior Director of Operations
Inquis Medical
Senior Director of Operations
Inquis Medical
Clinical-stage thrombectomy system developer for VTE
*This position is on-site. If you are planning to relocate to the Bay Area please let us know in your cover letter or at the top of your resume. We are unable to offer relocation assistance for this position*
As Senior Director of Operations, you will lead our manufacturing and operations as they scale their innovative medical device solutions. This is a pivotal leadership role for a proven operations leader who thrives in high-growth environments and has deep expertise in medical device manufacturing. You will build and scale operations from the ground up in our facility to increase volumes from 300 - 5k a month; implementing a robust MRP system, and create distribution networks that will support our company's ambitious growth trajectory.
WhatYou'llWorkOn:
Manufacturing& ProductionLeadership
SupplyChain& SystemsDevelopment
Quality& RegulatoryExcellence
TeamLeadership&OrganizationalDevelopment
FinancialManagement&Strategy
WhatYou'llContribute:
Education&Certifications
ExperienceRequirements
RequiredSkills&Abilities
Inquis Medical is an Equal Opportunity Employer and embraces diversity. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, status as a protected veteran, or any characteristic protected by applicable law.
Inquis Medical does not accept resumes or candidate submissions from third-party recruiters and/or vendors who are not expressly under current written contract.
Compensation Range 210000 - 250000 USD
Clinical-stage thrombectomy system developer for VTE
Inquis Medical is a clinical-stage medtech company developing the AVENTUS Thrombectomy System for non-surgical removal of blood clots in venous thromboembolic diseases. The system uses TrueClot tissue-sensing to give real-time feedback and distinguishes blood, clot, and vessel wall, while integrating navigation, aspiration, and a blood-return/filtration loop for single-pass clot removal with reduced blood loss. It differentiates itself with real-time tissue sensing, a single-pass approach, and an integrated blood filtration/return system that aims to improve precision and efficiency over existing devices. The company’s goal is to complete pivotal trials and commercially launch the AVENTUS system, initially for peripheral clots and later for pulmonary embolism, beginning with a 2025 market entry supported by a recent Series B round.
Explore more opportunities at Inquis Medical